Sign up for DML's newsletter

As the most reliable and balanced news aggregation service on the internet, DML News App offers the following information published by DAILYCALLER.COM:

“Fox News Sunday” anchor Chris Wallace pressed National Institutes of Health Director Francis Collins about President Joe Biden’s push for COVID-19 booster shots.

Wallace spoke with Collins about Biden’s plan — which would have all Americans begin receiving booster shots eight months after their initial vaccine doses — and the fact that the FDA had voted only to recommend boosters for those over 65 or with weakened immune systems.

The article goes on to state the following:

Wallace argued that Biden had gotten out ahead of the experts when he suggested that booster doses of the Pfizer vaccine would be available for all Americans in the coming days only to have the FDA advisory panel vote that down, 16-2.


“Back during the campaign, he talked a lot about ‘follow the science.’ Isn’t announcing a specific date and a specific plan for the general population before any of the regulars — the FDA, the CDC — have approved it, isn’t that the exact opposite of ‘follow the science’?” Wallace asked.

“They did encourage, and vote for, the administration of boosters to people over 65, and those at high risk of exposure,” Collins responded. “Those are the people who would be most likely to reach that eight-month period — because that’s how we prioritized initial immunizations back in January. So I don’t think there’s huge differences here.”

“Maybe we ought to be talking more about that than whether the president said this a month ago and FDA said this on Friday,” Collins continued, appearing to chastise Wallace for asking the question. “Let’s try to get the science right and do it transparently and openly so everybody sees what the process looks like.”

WATCH:

Listen to the latest daily DML podcasts below! Then please share. And if you have the DML NEWS APP, please tell people to download it today and help conservatives have a real voice.

To get more information about this article, please visit DAILYCALLER.COM.

Sign up for DML's newsletter
Previous articleWATCH: College football fans continue anti-Biden chant for third week in a row
Next articleWATCH LIVE: FBI holds presser after body found during search for Gabby Petito

8 COMMENTS

  1. Did Obiden take any of these shots? Is he going to take the BOOSTER shot? What about PELOSI? So many questions we should be asking. Wake up America

  2. “They did encourage, and vote for, the administration of boosters to people over 65, and those at high risk of exposure,” Collins responded.
    They are murdering our elderly and at risk Americans with this shot.

  3. I’m speaking for a great many seniors.
    We do not trust the “science” and are waiting until it receives all the safety guidelines accordingly by the FDA!
    “There is no typical length of time it takes for a drug to be tested and approved. It might take 10 to 15 years or more to complete all 3 phases of clinical trials before the licensing stage. But this time span varies a lot. There are many factors that affect how long it takes for a drug to be licensed.Feb 22, 2019
    https://www.cancerresearchuk.org › … “

    President Trump was a big proponent of “Right to Try”! As you read the follow, note the process and pay particular attention to the fact it is an INDIVIDUAL application and APPROVAL!
    I don’t recall applying for a “last ditch” experimental drug! Do you?

    “ FDA FACT SHEET
    Right to Try
    What is Right to Try?
    • Right to Try is one pathway for patients diagnosed with life-threatening diseases or conditions who have exhausted all approved treatment options and are unable to participate in a clinical trial to access certain drugs that have not been approved by the Food and Drug Administration (FDA).
    • Right to Try allows eligible patients to request access to certain investigational drugs (including biologics1) that have not yet been approved by the FDA.
    • Under Right to Try, patients and their doctors work with a company that is developing a drug or biologic to request access without involving FDA in the process.
    • The FDA does not review or approve Right to Try requests.
    How do I know if I am eligible to request access to a drug or biologic under
    Right to Try?
    Patients who are eligible under the Right to Try Act2 meet the following criteria:
    • You have a life-threatening disease or condition.
    • You have exhausted approved treatment options and are unable to participate in a
    clinical trial involving the drug or biologic, as certified by your doctor.
    • You (or your legally authorized representative) have given written informed
    consent to the doctor regarding the investigational drug.
    How do I know if a drug or biologic is available under Right to Try?
    • The Right to Try Act sets forth specific criteria for a drug or biologic to be eligible for this pathway, such as a drug or biologic being under clinical trial investigation.
    • The Right to Try Act does not require a manufacturer or sponsor to provide access to drugs or biologics. Further, FDA cannot require a manufacturer or sponsor to provide access to drugs or biologics under the Right to Try Act.”

    Is there any wonder, so many of us are questioning the “science”?

  4. Did anyone apply for this experimental drug, under Right To Try?
    Each application is filed for individually and approved or denied individually!

    “FDA FACT SHEET
    Right to Try
    What is Right to Try?
    • Right to Try is one pathway for patients diagnosed with life-threatening diseases or conditions who have exhausted all approved treatment options and are unable to participate in a clinical trial to access certain drugs that have not been approved by the Food and Drug Administration (FDA).
    • Right to Try allows eligible patients to request access to certain investigational drugs (including biologics1) that have not yet been approved by the FDA.
    • Under Right to Try, patients and their doctors work with a company that is developing a drug or biologic to request access without involving FDA in the process.
    • The FDA does not review or approve Right to Try requests.
    How do I know if I am eligible to request access to a drug or biologic under
    Right to Try?
    Patients who are eligible under the Right to Try Act2 meet the following criteria:
    • You have a life-threatening disease or condition.
    • You have exhausted approved treatment options and are unable to participate in a
    clinical trial involving the drug or biologic, as certified by your doctor.
    • You (or your legally authorized representative) have given written informed
    consent to the doctor regarding the investigational drug.
    How do I know if a drug or biologic is available under Right to Try?
    • The Right to Try Act sets forth specific criteria for a drug or biologic to be eligible for this pathway, such as a drug or biologic being under clinical trial investigation.
    • The Right to Try Act does not require a manufacturer or sponsor to provide access to drugs or biologics. Further, FDA cannot require a manufacturer or sponsor to provide access to drugs or biologics under the Right to Try Act.”

    Seniors are waiting for the peer review, that is the last step in a drug being approved by the FDA!
    The whole process from start to finish, takes 10 to 15 years, to put a drug on the market!

LEAVE A REPLY

Please enter your comment!
Please enter your name here